**Core tip:** This systematic review demonstrated that scaffold-based therapy for lesions of the talus (OLT) may produce favorable clinical outcomes. However, 96% of included studies were classified into the category of poor level of evidence and no papers were of good methodological quality. Therefore, careful attention should be paid when evaluating scaffold-based therapy for OLT. In addition, large variability and underreporting of clinical data between studies made it difficult to reliably compare the results. Further well-designed studies are necessary to determine the effectiveness of scaffold-based therapy for OLT, especially when compared to the available traditional treatments.

INTRODUCTION
============

Numerous surgical treatment strategies for osteochondral lesions of the talus (OLT) have been proposed, but a universally ideal treatment has yet to be established\[[@B1],[@B2]\]. The operative treatment for OLT can be divided into two broad categories: Reparative and replacement procedures. Reparative procedures aim to regenerate tissue with biomechanical properties similar to normal hyaline cartilage. Bone marrow stimulation (BMS) is the most common reparative procedure, which stimulates mesenchymal stem cell proliferation and promotes fibrous cartilage repair tissue at the defect site. However, the fibrous cartilage repair tissue has different biological and mechanical properties compared to native hyaline cartilage and is likely to degenerate over time\[[@B3]\]. Autologous chondrocyte implantation (ACI) is another reparative procedure that attempts to regenerate damaged cartilage with more hyaline-like repair tissue, but this procedure has the disadvantage of the need for a two-staged intervention, which increases both cost and the potential for morbidity\[[@B4]\].

Recently, tissue-engineering approaches using various types of bioavailable scaffolds has emerged with greater potential for cellular differentiation and maturation. The templates are typically seeded with elements selected to improve the quality of reparative cartilage and include stem cells and growth factors. Matrix-induced autologous chondrocyte transplantation (MACT) is a second-generation ACI technique, which uses a type I/III bilayer collagen membrane seeded with cultured autologous chondrocytes. However, MACT also requires a two stage procedure\[[@B5],[@B6]\]. Autologous matrix-induced chondrogenesis (AMIC) is a one-step scaffold-based therapy that combines bone marrow stimulation (BMS) with the use of a porcine collagen I/III matrix scaffold\[[@B7]\]. Bone marrow-derived cell transplantation *(*BMDCT) is also a one-step procedure and is a combination of concentrated bone marrow aspirate and scaffold material\[[@B8]\].

Scaffold-based therapy for OLT offers alternative reparative procedures and is quickly becoming more popular as data supporting clinical efficacy increases\[[@B9]\]. However, no consensus has been reached regarding the effectiveness of scaffold-based therapy on OLT to date.

The purpose of the current systematic review was to clarify the effectiveness of scaffold-based therapy for OLT based on available clinical evidence.

MATERIALS AND METHODS
=====================

Search strategy
---------------

Two independent reviewers performed a systematic review of the databases PubMed/MEDLINE and EMBASE in January 2017 based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines\[[@B10]\].

The combination of search terms were: (cartilage OR cartilage injury OR cartilage damage OR cartilage repair OR cartilage defect OR osteochondral lesion OR osteochondral dissecans OR osteochondral defect OR osteochondral injury OR osteochondral fracture OR osteochondritis dissecans) AND (ankle OR talus OR tibia OR talocrural joint) AND (scaffold OR scaffold-based repair OR matrix-assisted chondrocyte implantation OR cartilage regeneration OR osteochondral repair). The reference list of all articles and relevant studies were also scanned for additional articles potentially not identified through our electronic search alone.

The inclusion and exclusion criteria are shown in the Table [1](#T1){ref-type="table"}. No time limit was given to publication date.

###### 

Inclusion and exclusion criteria

  -------------------- --------------------------------------------------------------------------------------------
  Inclusion criteria   
                       Therapeutic clinical studies evaluating the effect of scaffolds for ankle cartilage repair
                       All patients included had \> 6-mo follow-up
                       Published in a peer-reviewed journal
                       Published in English
                       Full-text version available
  Exclusion criteria   
                       Review articles
                       Case reports
                       Technique articles
                       Cadaveric studies
                       Animal studies
                       *In vivo* studies
  -------------------- --------------------------------------------------------------------------------------------

The titles and abstracts were reviewed by applying the aforementioned criteria, and the full text of potentially relevant studies was then selected. Scaffold-based therapy for OLT was defined as operative treatment using any scaffolds for OLT.

Differences between reviewers were discussed until agreement was achieved, and the senior author was consulted in the event of persistent disagreement.

Assessment of level of evidence
-------------------------------

Two independent investigators reviewed each study and the LOE was determined using previously published criteria\[[@B11]\].

Assessment of methodological quality of evidence
------------------------------------------------

Two independent investigators evaluated the methodological quality of evidence (QOE) of the included studies using the Modified Coleman Methodology Score (MCMS) (Table [2](#T2){ref-type="table"})\[[@B12],[@B13]\]. Instances of discrepancy were resolved by consensus and if any disagreement persisted, a senior author was consulted and a consensus was reached. Excellent studies were considered those that scored 85 to 100 points; good studies scored 70 to 84 points; fair studies scored 55 to 69 points, and poor studies scored less than 55 points\[[@B14]\].

###### 

Modified Coleman Methodology Score

                                                                                        **Score**                                                                                          
  ------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- ----
  Part A: Only 1 score to be given for each section                                                                                                                                        
  Number of study patients                                                                                                                                                                 
                                                                                        \> 60                                                                                              10
                                                                                        41-60                                                                                              7
                                                                                        20-40                                                                                              4
                                                                                        \< 20, not stated                                                                                  0
  Mean follow-up (mo)                                                                                                                                                                      
                                                                                        \> 24                                                                                              5
                                                                                        12-24                                                                                              2
                                                                                        \< 12, not stated or unclear                                                                       0
  Number of different surgical procedures included in each reported outcome                                                                                                                
                                                                                        1                                                                                                  10
                                                                                        \> 1, but \> 90% of patients undergoing the 1 procedure                                            7
                                                                                        Not stated, unclear, or \< 90% of subjects undergoing the 1 procedure                              0
  Type of study                                                                                                                                                                            
                                                                                        Randomized controlled trial                                                                        15
                                                                                        Prospective cohort study                                                                           10
                                                                                        Retrospective cohort study                                                                         0
  Diagnostic certainty (MRI)                                                                                                                                                               
                                                                                        In all                                                                                             5
                                                                                        In \> 80%                                                                                          3
                                                                                        In \< 80%                                                                                          0
  Description of surgical procedure given                                                                                                                                                  
                                                                                        Adequate (technique stated and necessary details of that type of procedure provided)               5
                                                                                        Fair (technique only stated without elaboration)                                                   3
                                                                                        Inadequate, not stated, or unclear                                                                 0
  Description of postoperative rehabilitation                                                                                                                                              
                                                                                        Well described (ROM, WB, and sport)                                                                10
                                                                                        Not adequately described (2 items between ROM, WB, and sport)                                      5
                                                                                        Protocol not reported                                                                              0
  Part B: Scores may be given for each option in each of the 3 sections if applicable                                                                                                      
  Outcome criteria                                                                                                                                                                         
                                                                                        Outcome measures clearly defined                                                                   2
                                                                                        Timing of outcome assessment clearly stated (*e.g*., at best outcome after surgery or follow-up)   2
                                                                                        Objective, subjective, and imaging criteria                                                        6
                                                                                        2 items between objective, subjective, and imaging criteria                                        4
                                                                                        Objective, subjective, or radiological criteria                                                    2
  Procedure for assessing outcomes                                                                                                                                                         
                                                                                        Patients recruited (results not taken from surgeons\' files)                                       5
                                                                                        Investigator independent of surgeon                                                                4
                                                                                        Written assessment                                                                                 3
                                                                                        Completion of assessment by patinets themselves with minimal investigator assistance               3
  Description of patient selection process                                                                                                                                                 
                                                                                        Selection criteria reported and unbiased                                                           5
                                                                                        Recruitment rate reported                                                                          
                                                                                        \> 80%                                                                                             5
                                                                                        \< 80%                                                                                             3
                                                                                        Eligible patients not included in study satisfactorily accounted for or 100% recruitment           5

Data extraction and analysis
----------------------------

Two reviewers independently extracted data from each study and assessed variable reporting of outcome data using parameters of previously published criteria\[[@B15]\]. In addition, clinical outcomes and the percentage of patients who returned to sport at previous level were evaluated.

Statistical analysis
--------------------

All statistical analysis was performed using a commercially available statistical software package (SAS 9.3; SAS Institute, Inc., Cary, NC, United States). Descriptive statistics were calculated for each study and parameters analyzed. For each variable, the number and percentage of studies that reported the variable was calculated. Variables were reported as weighted average ± weighted standard deviation where applicable.

RESULTS
=======

After full text review, 28 clinical studies for a total of 897 ankles were identified for inclusion in the current study (Figure [1](#F1){ref-type="fig"})\[[@B4]-[@B8],[@B16]-[@B38]\]. The weighted mean follow-up was 37.7 (range 6-87) mo, with only three studies reporting a follow-up time of greater than five years\[[@B20],[@B22],[@B24]\].

![PRISMA flowchart outlining the systematic review.](WJO-8-798-g001){#F1}

Of the 28 clinical studies, there were 30 treatment groups, including six different scaffold-based therapies: 13 MACT\[[@B5],[@B6],[@B16]-[@B26]\], nine BMDCT\[[@B4],[@B8],[@B26]-[@B31]\], four AMIC\[[@B7],[@B32]-[@B34]\], two cartilage extracellular matrix\[[@B35],[@B36]\], one autologous collagen-induced chondrogenesis (ACIC)\[[@B37]\], and one cell free scaffold therapy\[[@B38]\]. All included studies of scaffold-based therapy were summarized in Table [3](#T3){ref-type="table"}. Patient demographics and clinical characteristics of each procedure are shown in Table [4](#T4){ref-type="table"}.

###### 

Studies of two-step and one-step procedures for ankle scaffold-based repair

  **Procedure**        **Product**                         **Scientific publication**           **Type of study**   **LOE**   **No. of patients**                       **Lesion size (cm^2^)**   **Follow-up (mo)**   **Results**
  -------------------- ----------------------------------- ------------------------------------ ------------------- --------- ----------------------------------------- ------------------------- -------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Two-step                                                                                                                                                                                                             
  MACT                 MACI                                Schneider et al\[[@B6]\], 2009       Case series         IV        20                                        2.3                       21                   Significant improvement in functional score
                                                                                                                                                                                                                       Pain improved in 70% of patients
                                                           Giza et al\[[@B5]\], 2010            Case series         IV        10                                        1.3                       24                   Significant clinical improvement at 1 yr and maintained at 2 yr
                                                           Aurich et al\[[@B16]\], 2011         Case series         IV        18                                        \-                        25                   Significant improvement in all clinical scores 64% were excellent or good Age and symptoms duration were correlated with results
                                                           Dixon et al\[[@B17]\], 2011          Case series         IV        25                                        1.3                       44                   72% improved symptoms 78% patients over 40 yr reported restricted recreational activity
                                                           Lee et al\[[@B18]\], 2013            Case series         IV        38                                        1.9                       24                   Functional outcomes improved significantly at 2 yr 68% were excellent or good outcome 75% ICRS grade I or II in 2^nd^ look arthroscopy at 1 yr
                                                           Johnson et al\[[@B19]\], 2013        Case series         IV        18                                        1.9                       82                   Functional outcomes improved at final follow-up
                                                           Giannini et al\[[@B20]\], 2014       Case series         IV        46                                        1.6                       87                   Significant clinical improvement at 1 yr and maintained at 3 yr; 3 failures
                       Hyalograft C                        Giannini et al\[[@B21]\], 2008       Case series         IV        46                                        1.6                       36                   Significant clinical improvement at 1 yr and 3 yr Results correlated with age and previous surgery Hyaline-like cartilage regeneration in histological evaluation
                                                           Battaglia et al\[[@B22]\], 2011      Case series         IV        20                                        2.7                       60                   Significant clinical improvement T2 mapping MRI showed 69% of lesion are covered with repair tissue
                                                           Nehrer et al\[[@B23]\], 2011         Case series         IV        13                                        \-                        47                   Significant clinical improvement in all cases
                                                           Domayer et al\[[@B24]\], 2012        Comparative study   III       18                                        1.2                       65                   Significant clinical improvement but no significant difference compared to MFX group No difference between MFX and MACT on T2 maps
                                                           Apprich et al\[[@B25]\], 2012        Case series         IV        10                                        1.2                       48                   Significant clinical improvement No differences in functional outcome and MOCART score between MFX and MACT
  Two-step                                                                                                                                                                                                             
  BMDCT                Spontostan Powder HYAFF-11          Giannini et al\[[@B8]\], 2009        Case series         IV        48 (25 HA membrane, 23 collagen powder)   2.1                       29                   Significant clinical improvement at 1 yr maintained at 2 yr Similar results with two scaffolds Correlation between clinical outcome and lesion size
                       Spontostan Powder HYAFF-11          Giannini et al\[[@B26]\], 2010       Comparative study   III       25 BMDCT 46 two-step MACI                 2.2 1.6                   39 57                Significant clinical improvement at 1 yr and further improvement at 3 yr 76% complete intergration with surrounding cartilage on MRI Hyaline-like cartilage tissue on histological evaluation
                       HYAFF-11                            Battaglia et al\[[@B27]\], 2011      Case series         IV        20                                        1.5                       24                   85% excellent or good clinical results at 2 yr 78% of lesion are covered with repair tissue comparable to hyaline cartilage
                       Spontostan Powder HYAFF-11          Giannini et al\[[@B28]\], 2013       Case series         IV        49                                        2.1                       29                   Significant clinical improvement at 1 yr with subsequent significant decrease at 2 and 3 yr 78% of repaired tissue similar to hyaline cartilage on T2 maps
                       Spongostan Powder                   Buda et al\[[@B29]\], 2014           Case series         IV        64                                        5.3                       53                   Clinical results peaked at 2 yr, declining gradually at follow-up of 6 yr
                       Biopad                              Cadossi et al\[[@B30]\], 2014        Comparative study   III       15 BMDCT 15 BMDCT with PEMF               2 1.9                     12 12                Significant clinical improvement in both groups
                       HYAFF-11                            Buda et al\[[@B4]\], 2015            Case series         IV        40                                        1.8                       48                   Significant clinical improvement Higher presence of hyaline-like cartilage in BMDCT than ACI on MRI T2 mapping
                       HYAFF-11 Spongostan Powder Biopad   Vannini et al\[[@B31]\], 2017        Case series         IV        140                                       2                         26                   Significant clinical improvement at 2 yr maintained at 4 yr Return to sports at preinjury level; 32.1% at 12 mo, 72.8% at 48 mo
  AMIC                 Unclear                             Wiewiorski et al\[[@B7]\], 2013      Case series         IV        23                                        \-                        23                   Significant clinical improvement
                       Chondro-Gide                        Valderrabano et al\[[@B32]\], 2013   Case series         IV        26                                        \-                        31                   Significant clinical improvement Normal signal intensity of repair tissue was seen in 15% on MRI
                       Chondro-Gide                        Kubosch et al\[[@B33]\], 2016        Case series         IV        17                                        2.4                       39                   Significant clinical improvement MOCART score correlated with AOFAS score
                       Chondro-Gide                        Wiewiorski et al\[[@B34]\], 2016     Case series         IV        60                                        \-                        47                   Calcaneal osteotomy was performed in 63% of patients Low rate for return to sports; postoperative sports activity levels remain stable when compared with preoperative levels
  Cartilage ECM        BioCartilage                        Desai S\[[@B35]\], 2016              Case series         IV        9                                         1.3                       12                   78% excellent, 22% good clinical outcomes
                                                           Clanton et al\[[@B36]\], 2014        Case series         IV        7                                         \-                        8                    Significant clinical improvement
  ACIC                 Cartifill                           Volpi P et al\[[@B37]\], 2014        Case series         IV        5                                         3.1                       6                    Significant clinical improvement at 6 mo
  Cell-free scaffold   MaioRegen^®^                        Christensen et al\[[@B38]\], 2015    Case series         IV        4                                         \-                        30                   No clinical scores improvement No improvement in MOCART score and 3 patients had 0%-10% bone formation in defect at 1 yr on CT

###### 

Patient demographics and clinical characteristics

                                                    **Procedure**                                                       
  ------------------------------------------------- --------------- ------------ ------------ --------- ------- ------- ----
  Treatment groups, *n*                             30              13           9            4         2       1       1
  Ankles, *n*                                       897             330          416          126       16      5       4
  Sex, male/female/unknown, *n*                     501/322/72      174/111/45   238/153/22   79/47/0   7/9/0   3/2/0   \-
  Age, yr, weighted mean (range)                    30.9 (19-61)    30.1         30.2         34.9      42.7    25.6    \-
  Duration of symptoms, mo, weighted mean (range)   34.3 (6-216)    34.5         36.5         23        \-      \-      \-
  Lesion size, mm^2^, weighted mean (range)         215 (116-527)   171          248          240       130     \-      \-
  Follow-up, mo, weighted mean (range)              37.7 (6-87)     45.8         32.7         38.2      10.4    6       30

LOE
---

There was one (3.6%) study of LOE II\[[@B30]\], three studies (10.7%) of LOE III\[[@B4],[@B24],[@B26]\], and 24 studies (85.7%) of LOE IV\[[@B5]-[@B8],[@B16]-[@B23],[@B25],[@B27]-[@B29],[@B31]-[@B38]\] (Table [5](#T5){ref-type="table"}) according to established criteria\[[@B11]\]. No study of LOE I was reported. The further data of LOE in each procedure group was shown in Table [5](#T5){ref-type="table"}.

###### 

Level and quality of evidence of included studies *n* (%)

                                                **Total Studies**   **Procedure groups**                                            
  --------------------- ----------------------- ------------------- ---------------------- ---------- --------- --------- --------- ---------
  Level of evidence                                                                                                                 
                        1                       0                   0                      0          0         0         0         0
                        2                       1 (3.6)             0                      2 (22.2)   0         0         0         0
                        3                       3 (10.7)            2 (15.4)               2 (22.2)   0         0         0         0
                        4                       24 (85.7)           11 (84.6)              5 (55.6)   4 (100)   2 (100)   1 (100)   1 (100)
  Quality of evidence                                                                                                               
                        Excellent (MCMS ≥ 85)   0                   0                      0          0         0         0         0
                        Good (MCMS 70-84)       0                   0                      0          0         0         0         0
                        Fair (MCMS 55-69)       7 (25.0)            3 (23.1)               4 (44.4)   0         0         0         0
                        Poor (MCMS \< 55)       21 (75.0)           10 (76.9)              5 (55.6)   4 (100)   2 (100)   1 (100)   1 (100)

QOE
---

The weighted mean MCMS of the overall population of studies was 49.3 ± 10.0 out of a possible 100 points. There were seven studies (25%) of fair quality \[[@B8],[@B18],[@B20],[@B21],[@B30],[@B31],[@B38]\] and the remainder (75%) were of poor quality\[[@B4]-[@B7],[@B16],[@B17],[@B19],[@B22]-[@B29],[@B32]-[@B37]\] (Table [5](#T5){ref-type="table"}). Further QOE data is shown in Table [5](#T5){ref-type="table"}.

Variable reporting of outcome data
----------------------------------

The defined data that were reported in the studies included in this review are listed and the each data according to procedure group is shown in Table [6](#T6){ref-type="table"}. General demographic information including age and gender were reported in 93% of the studies. While the study design, imaging data, and patient-reported outcomes were well-reported variables with 73%, 73% and 85% respectively, patient history was the least reported variable of all with 30% of the data being reported. Clinical variables were reported in only 49% of studies.

###### 

Data reported (in percentage)

                                                                                        **Procedure**                           
  --------------------------- --------------------------------------------------- ----- --------------- ----- ----- ----- ----- -----
  Procedure groups, *n*                                                           30    13              9     4     2     1     1
  Demographic information                                                         93    92              94    100   100   100   0
                              Sex                                                 90    85              89    100   100   100   0
                              Mean age + range                                    97    100             100   100   100   100   0
  Patient history                                                                 30    35              31    44    13    0     0
                              Body mass index                                     33    31              33    50    50    0     0
                              Mean duration of symptoms                           23    38              22    25    0     0     0
                              Previous traumatic experience(s)                    33    38              44    50    0     0     0
                              Activities of daily living/athletic participation   30    31              22    50    0     0     0
  Study design                                                                    73    71              78    72    56    63    38
                              Type of study                                       50    23              56    25    0     0     100
                              Number of patients                                  97    100             100   100   100   100   0
                              Percentage of patients in follow-up                 97    100             100   100   100   100   0
                              Consecutive patients                                23    23              22    50    0     0     0
                              Follow-up time + range/standard deviation           100   100             100   100   100   100   100
                              Method of lesion size measurement                   43    54              44    50    0     0     0
                              Lesion classification system utilized               77    77              100   50    50    100   0
                              Surgical approach used to access lesion             97    92              100   100   100   100   100
  Clinical variables                                                              49    53              50    58    33    33    33
                              Lesion size                                         93    100             100   75    50    100   100
                              Lesion location                                     77    77              100   75    50    0     0
                              Presence of cyst                                    13    23              0     25    50    0     0
                              Associated pathology                                13    23              0     25    0     0     0
                              Concomitant procedures                              20    15              22    50    0     0     0
                              Description of rehabilitation                       80    77              78    100   50    100   100
  Imaging data                                                                    73    81              83    75    50    0     100
                              Imaging used to identify lesion                     80    92              89    75    50    0     100
                              Imaging used at follow-up                           67    69              78    75    50    0     100
  Patient-reported outcomes                                                       85    85              100   88    0     100   100
                              Pain, function, and activity scale, pre-operative   80    77              100   75    0     100   100
                              Pain, function, and activity scale, at follow-up    90    92              100   100   0     100   100

Clinical outcomes were evaluated using a number of different scoring systems for scaffolds-based therapy for OLT (Table [7](#T7){ref-type="table"}). The American Orthopaedic Foot and Ankle Society (AOFAS) score was the most frequently utilized in 25 studies of the included\[[@B4]-[@B8],[@B16]-[@B18],[@B20]-[@B34],[@B37],[@B38]\]. Of the 25 studies that used AOFAS, 22 studies investigated both pre- and post-operative scores\[[@B4]-[@B8],[@B16],[@B18],[@B20]-[@B23],[@B25]-[@B32],[@B34],[@B37],[@B38]\].

###### 

Clinical outcome scores utilized in included studies *n* (%)

  **Score**               **Studies, total**   **Procedure group**                                          
  ----------------------- -------------------- --------------------- --------- --------- -------- --------- ---------
  AOFAS                   25 (89)              12 (92)               9 (100)   4 (100)   0 (0)    1 (100)   1 (100)
  VAS                     7 (25)               1 (8)                 2 (22)    4 (100)   0 (0)    1 (100)   0 (0)
  Tegner activity score   3 (11)               1 (8)                 0 (0)     1 (25)    0 (0)    0 (0)     1 (100)
  SF-36                   2 (7)                1 (8)                 2 (22)    0 (0)     0 (0)    0 (0)     0 (0)
  FFI                     2 (7)                1 (8)                 0 (0)     1 (25)    0 (0)    0 (0)     0 (0)
  FADI                    1 (4)                0 (0)                 0 (0)     0 (0)     1 (50)   0 (0)     0 (0)
  HSS                     1 (4)                1 (8)                 0 (0)     0 (0)     0 (0)    0 (0)     0 (0)
  LEAS                    1 (4)                1 (8)                 0 (0)     0 (0)     0 (0)    0 (0)     0 (0)
  AHS                     1 (4)                1 (8)                 0 (0)     0 (0)     0 (0)    0 (0)     0 (0)
  AAOS                    1 (4)                1 (8)                 0 (0)     0 (0)     0 (0)    0 (0)     0 (0)
  ARS                     1 (4)                0 (0)                 0 (0)     1 (25)    0 (0)    0 (0)     0 (0)
  Halasi score            1 (4)                0 (0)                 1 (11)    0 (0)     0 (0)    0 (0)     0 (0)
  Mazur ankle score       1 (4)                1 (8)                 0 (0)     0 (0)     0 (0)    0 (0)     0 (0)
  Cincinnati score        1 (4)                1 (8)                 0 (0)     0 (0)     0 (0)    0 (0)     0 (0)

AAOS: American Academy of Orthopaedic Surgeons; AHS: Ankle-Hindfoot Score; AOFAS: American Orthopaedic Foot and Ankle Society; ARS: Activity Rating Scale; FADI: Foot and Ankle Disability Index; FFI: Foot Function Index; HSS: Hannover Scoring System; LEAS: University of California Lower Extremity Activity Scale; SF-36: Short Form-36 Health Survey; VAS: Visual analog scale.

Twelve of 13 MACT groups reported pre and postoperative AOFAS scores and of the 310 patients who underwent MACT\[[@B5],[@B6],[@B16]-[@B18],[@B20]-[@B26]\], the mean AOFAS score improved from 59.1 to 86.7 at a mean follow-up of 47.9 mo. Of the 416 patients from the nine BMDCT groups\[[@B4],[@B8],[@B26]-[@B31]\], the mean AOFAS score improved from 61.1 to 88.2 at a mean of 32.7 mo of follow-up. Of the 126 patients from the four AMIC groups\[[@B7],[@B32]-[@B34]\], the mean AOFAS score improved from 50.7 to 82.3 at a mean follow-up of 38.2 mo. Of the two cartilage ECM studies included, one publication reported outcomes at less than one year follow-up\[[@B36]\], and the other one did not describe clinical outcomes\[[@B35]\]. There was only one publication reporting ACIC data but clinical evaluation was insufficient due to a follow-up of only six mo\[[@B37]\]. In the cell-free scaffold group, only one study was published, which showed no clinical improvement in AOFAS score at a mean 30 mo (from 48.7 to 52.7) follow-up. However, these results only included four studies\[[@B38]\].

In this systematic review, 12 procedure groups reported sequential clinical outcomes at two or more post-operative time points\[[@B4],[@B5],[@B8],[@B18],[@B20],[@B21],[@B26],[@B28]-[@B31]\]. Four groups, which were all BMDCT studies, found temporal improvement in AOFAS scores over the first 2-3 years of post-operative follow-up with a mean decrease in AOFAS score of 87.1 reported at a mean 41.8 mo follow-up\[[@B4],[@B28],[@B29],[@B31]\]. In contrast, eight groups, including four MACT and four BMDCT groups, demonstrated that there were no deteriorations during a weighted mean 38-mo follow-up\[[@B5],[@B8],[@B18],[@B20],[@B21],[@B26],[@B30]\].

Return to sport activity at previous level
------------------------------------------

Overall, eight studies (MACT: One study, AMIC: Two studies, BMDCT: five studies) reported that a mean 68.3% of patients receiving scaffold-based therapy with mean lesion size of 250 mm^2^ returned to previous sport activity at previous level\[[@B4],[@B8],[@B21],[@B28],[@B29],[@B31],[@B32],[@B34]\]. Of the MACT procedures, Giannini et al\[[@B21]\] showed that 20 of 29 patients (69%) returned to sport at previous levels. In patients treated with AMIC procedures, Valderrabano et al\[[@B32]\] reported only nine of 20 patients (45%) returned to previous sport activity level, and Wiewiorski et al\[[@B34]\] also showed no significant difference when comparing preoperative and postoperative activity scores (ARS, Tegner). BMDCT was the most reported in five studies, and of these studies, 74.5% of patients were able to resume sports at preinjury level, with a range of 69% to 78%\[[@B4],[@B8],[@B28],[@B29],[@B31]\].

DISCUSSION
==========

The results from this systematic review demonstrate that recommendations for scaffold-based therapy based solely on evidence is not yet conclusive. In the current evaluation, 96% of included studies in which scaffold-based therapy was performed for the treatment of OLT were classified into the category of poor LOE. In addition, of 28 included articles, no papers were of good or better methodological quality. According to the principles of evidence-based medicine\[[@B39]\], a high level of clinical evidence and good methodological quality are fundamentally warranted to treat patients because low LOE and QOE studies are more likely to show overestimated outcomes compared to higher LOE and QOE studies\[[@B40],[@B41]\]. Careful attention therefore should be paid when evaluating outcomes following the studies of scaffold-based therapy for OLT.

The results from the current systematic review demonstrate large variability and underreporting of clinical data between studies reflecting and inability to compare the results across studies. These inconsistencies and general underreporting of data make it difficult to pool data, which furthermore makes it difficult to draw conclusions about effectiveness of the use of scaffold in the treatment for OLT. As Hannon et al\[[@B15]\] described, adequate reporting of data in the studies of the treatment for OLT should be required to perform high quality studies, and investigators should be encouraged to implement data collection both before and after surgery according to recommended list described by Hannon et al\[[@B15]\] in this review, the categories of imaging data were reported in 73% of included studies. Compared with reporting of outcome data on microfracture for OLT in the systematic review by Hannon et al\[[@B15]\], imaging data was reported in only 39% among the studies. However, this review showed a higher percentage of reporting of imaging data (73%). Nevertheless, only 67% of studies used MRI for patient follow-up evaluation, although MRI evaluation for scaffold-based treatment of OLT is crucial because the aim of the use of scaffolds and is generally believed to promote the subchondral bone and cartilage repair. In addition, the categories of clinical variables and patient history were reported only with 49% and 30% respectively. As these data including BMI, lesion location, presence of cyst, associated pathology, and concomitant procedures can have significant effect on patient outcome, what is alarming is that appropriate information is not enough taken in the current studies.

Lesion size has been widely accepted as the most commonly used predictor of clinical outcomes after BMS for OLT\[[@B42],[@B43]\]. Choi et al\[[@B42]\] demonstrated that BMS should be indicated for lesions less than 150 mm^2^ and lesions greater than this value resulted in poor outcomes. More recently, Ramponi et al\[[@B13]\] suggested that BMS could be best reserved for lesion size of less than 107.4 mm^2^ rather than 150 mm^2^. In the current review, however, the mean lesion size treated with scaffolds was 215 mm^2^, which is much larger than traditional indication size for BMS or the most current new indication size of 107 mm^2\[13\]^. This suggests that the use of scaffolds may further improve the potential of reparative techniques. However, further well-designed studies are necessary to determine the effectiveness of scaffold-based therapy on OLT because of low LOE and QOE and the large variability in the data.

Despite of high frequency of OLT in the athletic population, little is reported regarding return to sport following surgical treatment of OLT in this population. In the current review, weighted mean 68.3% of patients receiving scaffold therapy with weighted mean 250 mm^2^ of lesion size returned to previous sport activity at previous level in eight studies. There are no studies investigating the effectiveness of BMS alone for athletic populations who have large lesion as described above, but Choi et al\[[@B42]\] reported clinical failure rate in patients with lesion area ≥ 150 mm^2^ was 80%. Furthermore, Chuckpaiwong et al\[[@B43]\] reported a 97% of failure rate in 32 patients with a lesion area ≥ 150 mm^2^. This suggests that the use of scaffolds may provide better outcomes than BMS alone for larger lesions but high quality studies are warranted. On the other hand, in replacement procedures, including autologous osteochondral transplantation, which is generally indicated for larger lesions, several studies reported that more than 90% of patients returned to play sport at previous levels\[[@B44],[@B45]\]. Although there is inconsistency in indications for the treatment strategy, the rate of return to sport following scaffold-based therapy appears to be relatively lower than AOT procedures. The highest rate of return to sport after scaffold-based therapy was only 78.0% in athletes treated with BMDCT\[[@B31]\]. However, there was variability of sport type, postoperative rehabilitation protocol, and time to return to sport, which makes it difficult to assess these results appropriately.

Our review found that there were 12 different scoring systems used to assess clinical outcomes, with AOFAS score being the most commonly used (89%). However, there remains no validated scoring system for the clinical follow-up for the treatment of OLT\[[@B13]\]. Moreover, four BMDCT groups have shown that clinical outcomes deteriorate after peaking at 2-3 year postoperatively\[[@B4],[@B28],[@B29],[@B31]\], whereas four MACT and four BMDCT groups have no deterioration during follow-up\[[@B5],[@B8],[@B18],[@B20],[@B21],[@B26],[@B30]\]. A potential reason for these lags in clinical outcome data may be the invalid clinical evaluation methods after OLT surgery in addition to the use of the different kinds of scaffolds. A novel validated scoring system for the clinical follow-up of the treatment for OLT are currently warranted.

The appropriate treatment for OLT is still controversial. While the ideal procedure would regenerate a tissue with biomechanical properties similar to normal hyaline cartilage, reparative techniques can offer the replacement of the articular cartilage with a hyaline-like repair tissue. Scaffolds have been introduced to improve the requirements of the cartilage regeneration process, as ACI, the first generation approach for cartilage treatment, has evident biological and surgical limitations\[[@B46]\]. In fact, the use of scaffolds has overcome the drawbacks and simplified the procedure. However, any available substitute materials have not yet matched the properties of the normal cartilage, and there is no consensus about the superior effectiveness of these procedures over the other procedures, including replacement procedures. While the scaffold-based treatment has shown promising clinical results in numerous studies of case series, the current systematic review showed low LOE and poor methodological quality of the use of scaffolds for OLT. Further long-term comparative studies are warranted to investigate the potential of a bioengineered approach compared to other treatments. Furthermore, the definitive indications for this technique, including lesion size and character of the lesion, still remains controversial\[[@B13]\].

This systematic review has several inherent limitations and/or potential biases. The criterion was limited to MEDLINE, EMBASE and Cochrane Library Database articles published exclusively in English. The variables may not be all inclusive of data in each study, but they should be a representative summary of the most commonly used data. Another inherent concern was the overlapping of cohorts or subgroups of several cohorts studies in longitudinal follow-up studies. Finally, the data extraction was not performed blindly, but was performed by two independent reviewers and later confirmed by the lead author.

In conclusion, this systematic review demonstrated that the scaffold-based therapy for the treatment of OLT may produce favorable clinical outcomes, but low level of evidence, poor quality of evidence, and the variability of the data have confounded the effectiveness of scaffold-based therapy for OLT. Further, well-designed studies, are necessary to determine the effectiveness of the use of scaffold for the treatment of OLT, especially when compared to available traditional treatments.

COMMENTS
========

Background
----------

Recently scaffold-based therapy for osteochondral lesions of the talus (OLT) has become more popular as an alternative reparative procedure. However, no consensus has been reached regarding the effectiveness of scaffold-based therapy in the treatment of OLT to date. In this study, the effectiveness of scaffold-based therapy was systematically reviewed based on available clinical evidence.

Research frontiers
------------------

Scaffolds have been introduced to improve the requirements of the cartilage regeneration process, as autologous chondrocyte implantation (ACI), the first generation approach for cartilage treatment, has evident biological and surgical limitations. Recently, the use of scaffolds has overcome the drawbacks and simplified the procedure.

Innovations and breakthroughs
-----------------------------

The scaffold-based treatment has shown promising clinical results in numerous studies of case series and the use of scaffolds may further improve the potential of reparative techniques. Retrieved manuscripts were reviewed by the authors, and the data were extracted.

Applications
------------

This systematic review suggests that the scaffold-based therapy for the treatment of OLT may produce favorable clinical outcomes, but low level of evidence, poor quality of evidence, and the variability of the data have confounded the effectiveness of scaffold-based therapy for OLT.

Terminology
-----------

Matrix-induced autologous chondrocyte transplantation is a second-generation ACI technique, which uses a type I/III bilayer collagen membrane seeded with cultured autologous chondrocytes. Autologous matrix-induced chondrogenesis is a one-step scaffold-based therapy that combines bone marrow stimulation with the use of a porcine collagen I/III matrix scaffold. Bone marrow-derived cell transplantation is also a one-step procedure and is a combination of concentrated bone marrow aspirate and scaffold material.

Peer-review
-----------

The paper adequately concludes what is already suspected in that variable quality, small studies with limited outcome data serve to confuse the authors' knowledge. It's a useful review.

Conflict-of-interest statement: Kennedy JG is a consultant for Arteriocyte, Inc.; has received research support from the Ohnell Family Foundation, Mr. and Mrs. Michael J Levitt, and Arteriocyte Inc.; is a board member for the European Society of Sports Traumatology, Knee Surgery, and Arthroscopy, International Society for Cartilage Repair of the Ankle, American Orthopaedic Foot and Ankle Society Awards and Scholarships Committee, International Cartilage Repair Society finance board.

Manuscript source: Invited manuscript

Specialty type: Orthopedics

Country of origin: United States

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): C, C

Grade D (Fair): 0

Grade E (Poor): 0

Peer-review started: March 28, 2017

First decision: April 17, 2017

Article in press: August 3, 2017

P- Reviewer: Lee SH, Malik H, Vulcano E S- Editor: Kong JX L- Editor: A E- Editor: Lu YJ

[^1]: Author contributions: All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting and critical revision and editing, and approval of the final version.

    Correspondence to: John G Kennedy, MD, MCh, MMSc, FRCS (Orth), Hospital for Special Surgery, 523 East 72^nd^ Street, Suite 507, New York, NY 10021, United States. <kennedyj@hss.edu>

    Telephone: +1-646-7978880 Fax: +1-646-7978966
